Abstract: A system for forming display holders, such as name badges, identification badges, name plates, signs and the like, from modular, interchangeable components. In one embodiment a display holder is provided comprising a display subassembly having a cover and a backer plate releasably connectable to the cover, the plate having a first connector located on a rear surface of the plate. The display holder also includes a second connector releasably connectable to the first connector for positioning the display subassembly relative to a support surface.

Abstract: A portable lock includes a wireless signal receiver. The lock may be unlocked by transmitting a wireless unlock signal from a portable device such as a cellular telephone. Various actuation mechanisms which may include a solenoid, motor or memory wire of a type that contracts when energized are provided in example embodiments. Self-locking embodiments are readily operated with one hand.

Abstract: A portable lock includes a wireless signal receiver. The lock may be unlocked by transmitting a wireless unlock signal from a portable device such as a cellular telephone. Various actuation mechanisms which may include a solenoid, motor or memory wire of a type that contracts when energized are provided in example embodiments. Self-locking embodiments are readily operated with one hand.

Abstract: A system for forming display holders, such as name badges, identification badges, name plates, signs and the like, from modular, interchangeable components. In one embodiment a display holder is provided comprising a display subassembly having a cover and a backer plate releasably connectable to the cover, the plate having a first connector located on a rear surface of the plate. The display holder also includes a second connector releasably connectable to the first connector for positioning the display subassembly relative to a support surface.

Abstract: The present invention provides isolated and purified polynucleotides, polypeptides, and antibodies related to mammalian (e.g., mouse and human) legumain and the novel legumain splice variant, ZB-1. The invention further relates to the use of these isolated and purified polynucleotides, polypeptides, and antibodies, as well as other legumain and ZB-1 agonists and antagonists, in modulating legumain and/or ZB-1 activity, expression, and/or secretion in a cell or cell population, e.g., monocytes, macrophages, foam cells, vascular endothelial cells, kidney proximal tubule cells, arterial endothelial cells, sites of inflammatory cell invasion into a vessel intima, and neointimal lesional areas of an artery. The invention also provides legumain and ZB-1 antagonists, e.g., antagonistic small molecules, antibodies and antibody fragments to legumain and ZB-1, legumain and ZB-1 inhibitory polypeptides, and legumain and ZB-1 inhibitory polynucleotides.

Abstract: A business development corporation (BDC) is formed according to novel selection methods which organize investment according to investor definitions of technology application. For example, healthcare companies can be organized according to their involvement with particular therapeutic and diagnostic areas.